Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.1%

6 terminated/withdrawn out of 192 trials

Success Rate

95.2%

+8.7% vs industry average

Late-Stage Pipeline

17 trials in Phase 3/4

Results Transparency

5 of 120 completed trials have results

Key Signals

19 recruiting5 with results6 terminated

Enrollment Performance

Analytics

N/A

90(62.9%)

Phase 1

31(21.7%)

Phase 4

13(9.1%)

Phase 2

5(3.5%)

Phase 3

4(2.8%)

143Total

N/A(90)

Phase 1(31)

Phase 4(13)

Phase 2(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (192)

Showing 20 of 192 trials

NCT06306391Phase 1Completed

Pharmacokinetics of Intravenous and Intranasal Formulations of Naloxone in Healthy Volunteers.

Role: lead

NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT07223450Phase 1Completed

A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling

Role: lead

NCT06074016Phase 1Completed

Pharmacokinetics in Oral and Intranasal Formulations of Zolmitriptan.

Role: lead

NCT07554729Recruiting

AN EXTENDED COHORT STUDY TO INVESTIGATE SUICIDAL BEHAVIOR IN SPAIN (THE SURVIVE 2 STUDY)

Role: lead

NCT06612554Not ApplicableRecruiting

Zn Supplementation in HIV Immunological Non Responders

Role: lead

NCT04610086Completed

Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Shared Decision Making and Satisfaction With Colorectal Cancer Screening. The CyDESA Study

Role: collaborator

NCT07504913Recruiting

Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41

Role: lead

NCT03848858Not ApplicableCompleted

Efficacy of EMDR Therapy, as Compared to Treatment as Usual, in Reducing Clinical Symptoms in People With HIV

Role: lead

NCT07310862Not ApplicableNot Yet Recruiting

Virtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple Sclerosis

Role: collaborator

NCT07253974Recruiting

Prospective Evaluation of Atrial Fibrillation-Related Stroke Patients in Rehabilitation Program (PEARL), an Observational Cohort Study

Role: lead

NCT07249294Not ApplicableActive Not Recruiting

Program to Avoid NSAIDs in Patients With Advanced Chronic Liver Disease

Role: lead

NCT06952452Phase 3Recruiting

Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)

Role: lead

NCT03585491Not ApplicableActive Not Recruiting

Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation

Role: collaborator

NCT02558933Not ApplicableCompleted

Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children

Role: collaborator

NCT07152145Not ApplicableNot Yet Recruiting

Pilot Study of tSCS for Improving Upper Limb Function in People With Multiple Sclerosis

Role: lead

NCT06163235Not ApplicableNot Yet Recruiting

Efficacy of a Mobile Application and Semi-attendance Program in Bariatric Surgery

Role: lead

NCT04084795Not ApplicableRecruiting

Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia

Role: lead

NCT07101887Not ApplicableRecruiting

Comparative Study Between the Use of Trapeziometacarpal Prostheses and the Usual Resection-tenosuspension Arthroplasty for the Treatment of Rhizarthrosis, Focusing on Changes in Pain (Measured With the VAS Scale) and Function (With the Quick-DASH).

Role: lead

NCT06454734Not ApplicableRecruiting

Shock Wave Therapy for Lower Limb Lymphedema

Role: lead